Tyrosine kinase inhibitors were well-tolerated among patients with different etiologies of advanced HCC with lower survival in non-viral patients
酪氨酸激酶抑制剂在不同病因引起的晚期肝细胞癌患者中耐受性良好，但非病毒感染患者的生存率较低。
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-05828-x
Barakat, Eman M F; Kohla, Mohamed; Dabees, Hossam; Shousha, Hend Ibrahim; Moustafa, Ehab F; El-Kassas, Mohamed; Aziz, Mona Shoukry; Elkhateeb, Eman; Abdelaziz, Ashraf Omar; Abdelmalek, Mohamed Omar; Azmy, Aly; Tawheed, Ahmed; Aboganob, Walaa Mosaad; Taha, Hossam; Lithy, Rania; Radwan, Ahmed; Ghoraba, Dalia; Sayed, Hamdy; Nassief, Anwar; Elhelbawy, Mostafa; Nabeel, Mohamed Mahmoud; Medhat, Mohamed A; Askar, Safaa Ragab; Marwan, Eman; Rewisha, Eman; Elbaz, Tamer; Ahmed, Sayed Hassan; Elfouly, Nevien Fouad; Abdeen, Nermeen; Abdelmaksoud, Ahmed Hosni; Abdeltawab, Asmaa A; Shamkh, Mostafa Abd Alfattah; Ramadan, Ahmed; Abdelrazek, Yasser Arafat; Bassam, Mohamed; Sayed, Sayed Ahmed; Hussein, Rasha Salah; Alrajhi, Ammar; Allam, Allam Elsayed; Seyam, Omnia A; Said, Mohamed
